You are here

  • Home
  • Archive
  • Volume 92, Issue 3
  • Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies

Article info

Article menu
XML
Neuro-inflammation
Short report
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies

Authors

  • Ronan N McGinty Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Adam Handel Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Teresa Moloney Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • Archana Ramesh Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Andrew Fower Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Emma Torzillo Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Holger Kramer MRC London Institute of Medical Sciences, Imperial College, London, UK PubMed articlesGoogle scholar articles
  • Stephen Howell Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, The University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  • Patrick Waters Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • Jane Adcock Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Arjune Sen Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • Bethan Lang Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • Sarosh R Irani Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sarosh R Irani, Oxford Autoimmune Neurology Group, Nuffield Dept of Clinical Neurosciences, John Radcliffe Hospital, Oxford OX3 9DU, UK; sarosh.irani{at}ndcn.ox.ac.uk
View Full Text

Citation

McGinty RN, Handel A, Moloney T, et al
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
Journal of Neurology, Neurosurgery & Psychiatry 2021;92:291-294.

Publication history

  • Received August 31, 2020
  • Revised September 28, 2020
  • Accepted October 8, 2020
  • First published November 20, 2020.
Online issue publication 
February 12, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.